• Parexel expands Ph I research capabilities in China biospectrumasia
    September 19, 2019
    Parexel recently was recognized as a leader in Phase I clinical development by Industry Standard Research in its 2019 CRO Quality Benchmarking Report. The company has eight offices and more than 1,700 employees across all functions in Greater China as wel
PharmaSources Customer Service